Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$44.63

-0.69 (-1.52%)

07:11
04/25/19
04/25
07:11
04/25/19
07:11

Bristol-Myers says Phase 2 CheckMate -714 trial did not meet primary endpoints

The company announced topline results from the Phase 2 CheckMate -714 trial evaluating Opdivo versus Opdivo plus Yervoy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. The study did not meet its primary endpoints.

  • 25

    Apr

  • 06

    May

  • 18

    May

  • 20

    May

  • 31

    May

BMY Bristol-Myers
$44.63

-0.69 (-1.52%)

04/01/19
WBLR
04/01/19
DOWNGRADE
WBLR
Market Perform
Celgene downgraded to Market Perform from Outperform at William Blair
William Blair analyst Andy Hsieh downgraded Celgene (CELG) to Market Perform from Outperform saying the recent proxy recommendations set the course for the takeover by Bristol-Myers Squibb (BMY) winning shareholder approval.
04/01/19
UBSW
04/01/19
DOWNGRADE
Target $102
UBSW
Neutral
Celgene downgraded to Neutral from Buy at UBS
UBS analyst Carter Gould downgraded Celgene (CELG) to Neutral from Buy while raising his price target for the shares to $102 from $94. After ISS and Glass Lewis on Friday recommended that Bristol-Myers Squibb (BMY) shareholders vote in favor of the proposed acquisition, and Starboard dropped its proxy solicitation in opposition, the analyst sees an increasingly high probability that Bristol's acquisition of Celgene will be completed. He sees any lingering risks around antitrust concerns and Revlimid litigation as unlikely to derail the deal.
04/02/19
BERN
04/02/19
DOWNGRADE
BERN
Market Perform
Celgene downgraded to Market Perform from Outperform at Bernstein
Bernstein analyst Aaron Gal downgraded Celgene (CELG) to Market Perform from Outperform as spread narrows. The analyst notes that the current controversy on Celgene is whether the Bristol-Myers (BMY) acquisition will close. With limited upside, no differentiated views on the main controversy, and ahead of the shareholder vote on April 12th, the analyst is moving to the sidelines.
04/05/19
CANT
04/05/19
DOWNGRADE
Target $100
CANT
Neutral
Cantor sees Bristol deal closing, downgrades Celgene to Neutral
Cantor Fitzgerald analyst Alethia Young downgraded Celgene (CELG) to Neutral from Overweight with an unchanged price target of $100. The analyst expects the takeover by Bristol-Myers (BMY) to close.

TODAY'S FREE FLY STORIES

BSQR

Bsquare Corp

$1.23

-0.01 (-0.81%)

09:06
06/27/19
06/27
09:06
06/27/19
09:06
Hot Stocks
Bsquare Corp selected by Arcus FM in the U.K. »

Bsquare announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMP

Adamis Pharmaceuticals

$1.29

0.03 (2.38%)

09:05
06/27/19
06/27
09:05
06/27/19
09:05
Hot Stocks
Adamis Pharmaceuticals files two motions, lawsuit in response to kaleo suit »

Adamis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

FDX

FedEx

$159.92

3.92 (2.51%)

09:04
06/27/19
06/27
09:04
06/27/19
09:04
Recommendations
FedEx analyst commentary  »

FedEx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 31

    Jul

  • 17

    Sep

  • 13

    Nov

OSTK

Overstock.com

$13.54

2.765 (25.66%)

09:03
06/27/19
06/27
09:03
06/27/19
09:03
Hot Stocks
Overstock.com subsidiary tZERO launches crypto wallet mobile app »

Overstock.com announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$18.98

-0.36 (-1.86%)

09:03
06/27/19
06/27
09:03
06/27/19
09:03
Hot Stocks
Yext and Hootsuite launch platform integration for customer reviews »

Yext announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

YEXT

Yext

$18.98

-0.36 (-1.86%)

09:03
06/27/19
06/27
09:03
06/27/19
09:03
Hot Stocks
Yext and Hootsuite launch platform integration for customer reviews »

Yext announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

F

Ford

$9.90

0.06 (0.61%)

09:01
06/27/19
06/27
09:01
06/27/19
09:01
Hot Stocks
Ford to cut 12,000 jobs in Europe by end of 2020 »

Ford said in a statement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jul

  • 24

    Jul

  • 23

    Oct

VBLT

VBL Therapeutics

$1.17

-0.01 (-0.85%)

09:01
06/27/19
06/27
09:01
06/27/19
09:01
Initiation
VBL Therapeutics initiated  »

Oppenheimer bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

09:01
06/27/19
06/27
09:01
06/27/19
09:01
Hot Stocks
Ovid Therapeutics expects interim data from ENDYMION trial in Q3 »

Ovid continues to enroll…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

09:00
06/27/19
06/27
09:00
06/27/19
09:00
Hot Stocks
Ovid Therapeutics expects Phase 2 ROCKET trial results year-end or early 2020 »

The Phase 2 ROCKET trial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
06/27/19
06/27
09:00
06/27/19
09:00
General news
Treasury Action: the markets were little changed on the data »

Treasury Action: the…

09:00
06/27/19
06/27
09:00
06/27/19
09:00
General news
The 10k initial claims rise to 227k »

The 10k initial claims…

08:59
06/27/19
06/27
08:59
06/27/19
08:59
Conference/Events
Senate Banking, Housing & Urban Affairs Committee to hold a hearing »

The Committee holds a…

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

08:59
06/27/19
06/27
08:59
06/27/19
08:59
Hot Stocks
Ovid Therapeutics plans to enroll patients in Phase 3 NEPTUNE trial in Q3 »

Following an End-of-Phase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$9.45

-0.03 (-0.32%)

08:59
06/27/19
06/27
08:59
06/27/19
08:59
Recommendations
AMC Entertainment analyst commentary at Barrington »

AMC Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFI

Infinity Pharmaceuticals

$1.68

0.01 (0.60%)

08:58
06/27/19
06/27
08:58
06/27/19
08:58
Initiation
Infinity Pharmaceuticals initiated  »

Oppenheimer bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAGE

WageWorks

$51.65

0.91 (1.79%)

, HQY

HealthEquity

$62.16

-2.5 (-3.87%)

08:58
06/27/19
06/27
08:58
06/27/19
08:58
Hot Stocks
Fly Intel: Pre-market Movers »

UP AFTER EARNINGS:…

WAGE

WageWorks

$51.65

0.91 (1.79%)

HQY

HealthEquity

$62.16

-2.5 (-3.87%)

WBA

Walgreens Boots Alliance

$52.40

-0.59 (-1.11%)

KBH

KB Home

$23.58

-0.24 (-1.01%)

OFG

OFG Bancorp

$20.68

0.305 (1.50%)

NVAX

Novavax

$5.52

-0.08 (-1.43%)

CAG

Conagra Brands

$28.94

0.035 (0.12%)

MKC

McCormick

$150.58

-2.545 (-1.66%)

PDCO

Patterson Companies

$24.90

0.7 (2.89%)

PIR

Pier 1 Imports

$8.80

0.14 (1.62%)

RAD

Rite Aid

$7.11

0.26 (3.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 17

    Jul

08:58
06/27/19
06/27
08:58
06/27/19
08:58
Conference/Events
Jefferies to hold a summit »

Private Company Frac Sand…

08:56
06/27/19
06/27
08:56
06/27/19
08:56
Conference/Events
JMP Securities to hold a forum »

Boston Real Estate 1:1…

08:55
06/27/19
06/27
08:55
06/27/19
08:55
Conference/Events
Deutsche Bank to hold a conference »

Quarterly Healthcare…

ORIT

Oritani Financial

$16.53

0.3 (1.85%)

, VLY

Valley National

$10.12

-0.065 (-0.64%)

08:55
06/27/19
06/27
08:55
06/27/19
08:55
Upgrade
Oritani Financial, Valley National rating change at Sandler ONeill »

Oritani Financial…

ORIT

Oritani Financial

$16.53

0.3 (1.85%)

VLY

Valley National

$10.12

-0.065 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$37.05

4.34 (13.27%)

, TSLA

Tesla

$219.22

-0.47 (-0.21%)

08:55
06/27/19
06/27
08:55
06/27/19
08:55
Options
Notable open interest changes for June 27th »

Wednesday's total…

MU

Micron

$37.05

4.34 (13.27%)

TSLA

Tesla

$219.22

-0.47 (-0.21%)

AAPL

Apple

$199.79

4.18 (2.14%)

T

AT&T

$32.53

-0.02 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 24

    Jul

ASV

ASV Holdings

$1.64

-0.11 (-6.29%)

08:55
06/27/19
06/27
08:55
06/27/19
08:55
Hot Stocks
Breaking Hot Stocks news story on ASV Holdings »

ASV Holdings trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:55
06/27/19
06/27
08:55
06/27/19
08:55
Conference/Events
Oppenheimer to hold a summit »

Summit for Emerging…

ACRS

Aclaris Therapeutics

$4.45

0.06 (1.37%)

08:54
06/27/19
06/27
08:54
06/27/19
08:54
Recommendations
Aclaris Therapeutics analyst commentary  »

Aclaris trading near cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.